Trinity Capital Inc. is thrilled to add Formlogic to its portfolio, expecting the company's expansion. Formlogic's CEO is keen to modernize the industrial supply chain and keep skilled manufacturing in the US.
Trinity Capital believes that Carr's experience in the venture sphere will be invaluable as the company continues to grow and invest in disruptive companies. Carr is excited to join Trinity and contribute to its continued growth.
Trinity sees potential for advancements in gene therapy through Taysha's Rett syndrome treatments. Taysha believes the support from Trinity strengthens its vision to transform lives of patients with devastating diseases.
Trinity Capital股票讨论
• $Arcus Biosciences (RCUS.US)$ +11.2% (appointed to join S&P SmallCap 600)
• $Sphere 3d (ANY.US)$ +10.13% (mutually agreed to terminate merger agreement with Gryphon Digital Mining)
• $Theravance Biopharma (TBPH.US)$ +3.05% (announced results from Study 0170)
• $嘉年华存托凭证 (CUK.US)$ +4.7% (reported that March 28-April 3 was the busiest booking week in company history)
• $Castle Biosciences (CSTL.US)$ +4.4% (agreed to acquire Althe...
暂无评论